Clinical Trials on Poliomyelitis

Total 225 results

CanSino Biologics Inc.
Novotech (Australia) Pty Limited

Active, not recruiting

A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults

Poliomyelitis

Australia
Fidec Corporation
Bill and Melinda Gates Foundation

Completed

A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV

Poliomyelitis

Dominican Republic, Panama
Centers for Disease Control and Prevention
International Centre for Diarrhoeal Disease Research, Bangladesh

Completed

Duration of IPV Priming and Antibody Decay

Poliomyelitis

Bangladesh
GlaxoSmithKline

Completed

Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants

Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Poliomyelitis Vaccines

Singapore
Sinovac Biotech Co., Ltd

Recruiting

A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vaccine

Poliomyelitis | Polio

Pakistan, Bangladesh
Aga Khan University
World Health Organization

Unknown

Comparison of Immunity Following IPV Versus fIPV: a Community Based Randomized Controlled Trial in Pakistan (CODI)

Poliomyelitis | Immunization; Infection | Poliovirus Vaccine, Inactivated

Pakistan
Sanofi Pasteur, a Sanofi Company

Completed

Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children Who Received Different Pertussis Primary Vaccine Regimens in Republic of South Africa

Pertussis Immunisation | Diphtheria Immunisation | Tetanus Immunisation | Poliomyelitis Vaccine

South Africa
Aga Khan University

Recruiting

Community Engagement and Conditional Incentives to Accelerate Polio (GLIDE)

Polio | Incentives | Immunization; Infection

Pakistan
Eastern Virginia Medical School
NanoPass Technologies Ltd

Completed

Intradermal Versus Intramuscular Polio Vaccine Booster in HIV-Infected Subjects (IDIPV)

Polio Immunity

United States
Centers for Disease Control and Prevention
Tribhuvan University, Nepal

Completed

Diarrhea and Bivalent Oral Polio Vaccine Immunity

Diarrhea | Polio | Seroimmunity

Nepal
Bilthoven Biologicals
Serum Institute of India Pvt. Ltd.

Completed

A Clinical Study Comparing Safety and Immunogenicity of bOPV of Bilthoven Biologicals

Immune Response to Oral Polio Vaccine

Bangladesh
Aga Khan University
Bill and Melinda Gates Foundation; World Health Organization; UNICEF; Peshawar... and other collaborators

Unknown

To Develop, Implement and Evaluate the Polio Demonstration Project Comprising of a Community Based Intervention Package for Polio Eradication in Pakistan

Polio | Polio Sero Conversion | Polio Sero Prevalence | Immunization Coverage

Pakistan
GlaxoSmithKline

Completed

Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese Toddlers

Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Poliomyelitis-Haemophilus Influenzae Type b Vaccines

Vietnam
National Institute of Neurological Disorders and...

Completed

Brain Physiology in Polio Survivors

Postpoliomyelitis

United States
Royal College of Surgeons, Ireland
Beaumont Hospital; Post Polio Support Group Ireland

Completed

Arm Cycling to Improve Fitness in Polio Survivors

Postpoliomyelitis Syndrome

Ireland
GlaxoSmithKline

Completed

Study to Evaluate the Safety of Co-administration of GSK Biologicals' Poliorix and Infanrix in Healthy Children in Russia

Poliomyelitis

Russian Federation
National Institute of Neurological Disorders and...

Completed

Electromyography to Diagnose Neuromuscular Disorders

Healthy | Postpoliomyelitis Syndrome | Neuromuscular Disease

United States
PATH
Christian Medical College, Vellore, India; Ministry of Science and Technology...

Completed

Zinc and/or Probiotic Supplementation of Rotavirus and Oral Polio Virus Vaccines

Immunity to Oral Rotavirus Vaccine | Immunity to Oral Polio Vaccine | Shedding of Oral Rotavirus Vaccine

India
University of Vermont

Completed

Evaluation of Safety, Reactogenicity and Immunogenicity of Fractional-dose Inactivated Polio Vaccine (fIPV) Given Intradermally With Double Mutant Enterotoxigenic Escherichia Coli Heat Labile Toxin (dmLT) Adjuvant

Polio

United States
Jiangsu Province Centers for Disease Control and...
Beijing Minhai Biotechnology Co., Ltd

Completed

Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine.

Polio and Post-Polio Syndrome

China
Koç University

Completed

Whole Body Vibration on Muscle Strength in Patients With Postpolio Syndrome

Postpolio Syndrome

Turkey
Hadassah Medical Organization

Completed

Activity and Fatigue of the Respiratory Muscles and Pulmonary Characteristics in Post-Polio Patients

Post-polio Syndrome

Israel
Haukeland University Hospital

Completed

Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg)

Post-Polio Syndrome
GlaxoSmithKline

Completed

Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Poliomyelitis-Haemophilus Influenzae Type b Vaccines

Sweden, Norway
Azienda Ospedaliera Universitaria Integrata Verona

Completed

Intravenous Immunoglobulins for Post-Polio Syndrome

Post-polio Syndrome
Dirk Fischer

Completed

L-Citrulline in Patients With Post-Polio Syndrome

Post-Polio Syndrome

Switzerland
Merck Sharp & Dohme LLC

Completed

Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of RotaTeq® (V260) and Inactivated Poliomyelitis Vaccine in Healthy Chinese Infants (V260-074)

Prevention of Rotavirus Gastroenteritis in Infants and Children Caused by Serotypes G1, G2, G3, G4, and G9

China
University Hospital, Basel, Switzerland
University Children's Hospital Basel

Unknown

Spinal Cord Gray Matter Imaging in Post Polio Syndrome

Post-polio Syndrome

Switzerland
Sanofi Pasteur, a Sanofi Company

Completed

Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE

Tetanus | Diphtheria | Poliomyelitis

France
International Vaccine Institute
Bill and Melinda Gates Foundation; University of Vermont; University of Virginia and other collaborators

Completed

Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA (PROVIDE)

Poliomyelitis | Tropical Enteropathy

India
National Institute of Neurological Disorders and...

Completed

Study of "Post-Polio Syndrome"

Poliomyelitis | Postpoliomyelitis Syndrome

United States
Calliditas Therapeutics AB

Completed

Efficacy and Safety of Xepol (Human Immunoglobulin) in Subjects With Post-Polio Syndrome (PPS)

Post Polio Syndrome, PPS

Sweden
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b Vaccines

Finland, Australia, Spain, Italy, Canada, Czechia
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria Meni

Poland
Instituto Grifols, S.A.

Terminated

Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome (FORCE)

Post-polio Syndrome

United States, Denmark, Spain, Germany, Poland, Canada, Czechia, Italy, Netherlands
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria Meni

Poland
GlaxoSmithKline

Completed

Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b Vaccines

India
Aga Khan University
National Institutes of Health (NIH); World Health Organization

Completed

IPV in Moderate to Severe Chronic Malnourished 9-12 Month Old Children in Karachi. (MIPV)

Immunity to Polio Vaccines in Malnourished Infants | Immunity to Polio Vaccines in Non-malnourished Infants

Pakistan
GlaxoSmithKline

Completed

Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults

Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis

France, Germany
Associação de Assistência a Criança Deficiente

Completed

Quality of Life in Adult Neurological Patients

Acquired Brain Injury | Poliomyelitis | Spinal Cord Injury
National Institute of Neurological Disorders and...

Terminated

Modafinil to Treat Fatigue in Post-Polio Syndrome

Postpoliomyelitis Syndrome

United States
GlaxoSmithKline

Completed

Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children

Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis

United Kingdom
GlaxoSmithKline

Completed

Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.

Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis

Italy
Biolab Sanus Farmaceutica

Withdrawn

A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome

Postpoliomyelitis Syndrome

Brazil
GlaxoSmithKline

Completed

Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b Vaccines

Finland, Australia, Spain, Italy, Canada, Czechia
Istanbul Physical Medicine Rehabilitation Training...

Completed

Evaluation of Fatigue Severity, Mood, and Quality of Life in Post-Polio Syndrome

Fatigue | Polio | Polio and Post-polio Syndrome

Turkey
Shirley Ryan AbilityLab
Otto Bock Healthcare Products GmbH

Active, not recruiting

Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis

Arthritis | Spinal Cord Injuries | Poliomyelitis | Post-polio Syndrome | Lower Motor Neurone Lesion

United States
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine

Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b

China
Sanofi Pasteur, a Sanofi Company

Completed

REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-old Children

Tetanus | Diphtheria | Poliomyelitis

France
GlaxoSmithKline

Completed

Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine

Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b

Korea, Republic of

Clinical Trials on Poliomyelitis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations